These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6747601)

  • 21. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
    Neumann DA; Rose NR; Ansari AA; Herskowitz A
    J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.
    Ilbäck NG; Fohlman J; Slorach S; Friman G
    J Immunol; 1989 May; 142(9):3225-8. PubMed ID: 2540239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
    Kishimoto C; Kurokawa M; Ochiai H
    J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
    Kawai C; Matsumori A; Kumagai N; Tokuda M
    Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
    Kennedy JR
    J Immunol; 1990 Mar; 144(6):2446-7. PubMed ID: 2155966
    [No Abstract]   [Full Text] [Related]  

  • 31. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
    Rabausch-Starz I; Neu N; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents.
    Rezkalla S; Khatib G; Khatib R
    J Lab Clin Med; 1986 Apr; 107(4):393-5. PubMed ID: 2420912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.
    Godeny EK; Gauntt CJ
    J Immunol; 1986 Sep; 137(5):1695-702. PubMed ID: 3018079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elution of autoantibodies from the hearts of coxsackievirus-infected mice.
    Neumann DA; Lane JR; LaFond-Walker A; Allen GS; Frondoza C; Herskowitz A; Rose NR
    Eur Heart J; 1991 Aug; 12 Suppl D():113-6. PubMed ID: 1655441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
    Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
    Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of MIP-2 in coxsackievirus B3 myocarditis.
    Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
    J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
    Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
    Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.